KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Income from Non-Controlling Interests (2016 - 2025)

Pfizer (PFE) has disclosed Income from Non-Controlling Interests for 17 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests changed N/A to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $41.0 million for FY2025, 32.26% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was $8.0 million at Pfizer, down from $9.0 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $26.0 million in Q3 2021, with the low at $6.0 million in Q2 2022.
  • Average Income from Non-Controlling Interests over 5 years is $10.4 million, with a median of $9.0 million recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests skyrocketed 225.0% in 2021, then plummeted 76.92% in 2022.
  • Over 5 years, Income from Non-Controlling Interests stood at $12.0 million in 2021, then grew by 25.0% to $15.0 million in 2022, then plummeted by 40.0% to $9.0 million in 2023, then decreased by 11.11% to $8.0 million in 2024, then changed by 0.0% to $8.0 million in 2025.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $8.0 million, $9.0 million, and $18.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.